This topic contains a solution. Click here to go to the answer

Author Question: What are the major factors in the pathophysiology of RDS? 1. Qualitative surfactant deficiency 2. ... (Read 33 times)

geoffrey

  • Hero Member
  • *****
  • Posts: 880
What are the major factors in the pathophysiology of RDS? 1. Qualitative surfactant deficiency 2. Increased alveolar surface area 3. Increased small airways compliance 4. Presence of the ductus arteriosus
 
  a. 1 and 2 only
  b. 1 and 3 only
  c. 1, 3, and 4 only
  d. 1, 2, 3, and 4

Question 2

What is the first clinical sign of RDS in the newborn infant?
 
  a. Cyanosis
  b. Wheezing
  c. Hypertension
  d. Tachypnea



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Sophiapenny

  • Sr. Member
  • ****
  • Posts: 339
Answer to Question 1

ANS: C
The major factors in the pathophysiology of RDS are qualitative surfactant deficiency, decreased alveolar surface area, increased small airways compliance, and the presence of the ductus arterio-sus.

Answer to Question 2

ANS: D
Tachypnea usually occurs first.




geoffrey

  • Member
  • Posts: 880
Reply 2 on: Jul 16, 2018
:D TYSM


LegendaryAnswers

  • Member
  • Posts: 341
Reply 3 on: Yesterday
Excellent

 

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

The term pharmacology is derived from the Greek words pharmakon("claim, medicine, poison, or remedy") and logos ("study").

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library